Daniel S Kim, MD
Psychiatry · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Offices
- 2
Offices
2 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kim’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A87628 · Current
Licensed to practise in California · since 2004 · expires 2027-11-30 · Loma Linda University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$76,441
Medicare paid this office $76,441 for 145 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 48 | $32,618 | $70 |
| Return visit (30+ min) | 61 | $12,944 | $119 |
| Therapy using electrical currents | 36 | $10,124 | $92 |
| Long return visit (40+ min) | 19 | $5,865 | $168 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $3,389 | $106 |
See all 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 48 | $32,618 | $70 |
| Return visit (30+ min) | 61 | $12,944 | $119 |
| Therapy using electrical currents | 36 | $10,124 | $92 |
| Long return visit (40+ min) | 19 | $5,865 | $168 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $3,389 | $106 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,549 | $116 |
| Hospital discharge day management, 30 minutes or less | 21 | $1,777 | $74 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 49 | $1,150 | $15 |
Who their Medicare patients are
145 Original Medicare patients in 2024. Average age 74 · Under 65 10% · 85 and older 8% · Women 64% · Also on Medicaid 23% · Health risk score 1.43. Above the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: Depression 75% · High blood pressure 66% · Diabetes 30% · Dementia 30% · Chronic kidney disease 28% · Coronary heart disease 23% · Cancer 19% · Atrial fibrillation 14% · Stroke 13% · Heart failure 10% · COPD 10%.
The office billed $435,399, Medicare allowed $97,020 and paid $76,441; for 935 services of 23 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 145 | 935 | 74 | 1.43 | $435,399 | $76,441 |
| 2023 | 116 | 875 | 74 | 1.66 | $375,877 | $68,110 |
| 2022 | 126 | 778 | 75 | 1.53 | $323,254 | $58,256 |
| 2021 | 133 | 881 | 74 | 1.82 | $341,799 | $64,822 |
| 2020 | 126 | 838 | 75 | 1.89 | $328,900 | $58,596 |
| 2019 | 132 | 781 | 76 | 1.61 | $247,005 | $57,695 |
| 2018 | 113 | 711 | 72 | 1.89 | $152,995 | $46,272 |
| 2017 | 144 | 676 | 72 | 1.81 | $160,885 | $44,277 |
| 2016 | 150 | 1,140 | 78 | 1.88 | $252,770 | $77,718 |
| 2015 | 219 | 1,448 | 78 | 1.46 | $306,824 | $92,905 |
| 2014 | 198 | 1,644 | 79 | 1.48 | $244,250 | $86,685 |
| 2013 | 179 | 1,468 | 79 | 1.60 | $216,383 | $68,065 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 42 | $23,241 | $71 |
| Return visit (30+ min) | 48 | $11,483 | $114 |
| Therapy using electrical currents | 26 | $9,964 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $4,502 | $107 |
| Long return visit (40+ min) | 15 | $3,578 | $170 |
| Telehealth originating site facility fee | 55 | $3,008 | $21 |
| Hospital discharge day management, more than 30 minutes | 22 | $2,278 | $104 |
| Short return visit (20+ min) | 15 | $1,858 | $77 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,753 | $117 |
| Psychotherapy with evaluation and management visit, 30 minutes | 15 | $1,318 | $63 |
| Hospital discharge day management, 30 minutes or less | 11 | $816 | $74 |
2022: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 37 | $17,083 | $64 |
| Return visit (30+ min) | 37 | $10,284 | $117 |
| Therapy using electrical currents | 25 | $8,670 | $94 |
| Long return visit (40+ min) | 41 | $8,056 | $152 |
| Telehealth originating site facility fee | 71 | $3,523 | $21 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $2,407 | $93 |
| Hospital discharge day management, more than 30 minutes | 17 | $1,646 | $91 |
| Short return visit (20+ min) | 12 | $1,380 | $77 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,332 | $121 |
2021: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $20,692 | $66 |
| Return visit (30+ min) | 46 | $12,652 | $115 |
| Therapy using electrical currents | 23 | $8,107 | $91 |
| Long return visit (40+ min) | 23 | $4,831 | $173 |
| Telehealth originating site facility fee | 81 | $3,919 | $21 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,604 | $124 |
| Short return visit (20+ min) | 21 | $2,497 | $89 |
| Hospital discharge day management, more than 30 minutes | 24 | $2,376 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,984 | $94 |
| Psychotherapy with evaluation and management visit, 30 minutes | 15 | $1,111 | $58 |
2020: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 50 | $19,492 | $64 |
| Therapy using electrical currents | 24 | $10,287 | $100 |
| Short return visit (20+ min) | 32 | $6,087 | $68 |
| Return visit (30+ min) | 24 | $3,851 | $101 |
| Hospital discharge day management, more than 30 minutes | 28 | $2,891 | $100 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,760 | $125 |
| Telehealth originating site facility fee | 51 | $2,676 | $21 |
| Telephone medical discussion with physician, 21-30 minutes | 20 | $2,556 | $98 |
| Psychotherapy with evaluation and management visit, 30 minutes | 16 | $1,826 | $61 |
2019: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $23,227 | $65 |
| Short return visit (20+ min) | 48 | $5,304 | $72 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $3,465 | $124 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $3,396 | $94 |
| Hospital discharge day management, more than 30 minutes | 31 | $3,173 | $99 |
| Return visit (30+ min) | 25 | $3,014 | $69 |
| Return visit (30+ min) | 15 | $2,609 | $104 |
| Psychotherapy with evaluation and management visit, 30 minutes | 28 | $2,603 | $54 |
| Psychotherapy with evaluation and management visit, 30 minutes | 23 | $2,578 | $63 |
| New patient visit (45+ min) | 11 | $1,706 | $155 |
| Short return visit (20+ min) | 25 | $1,346 | $41 |
2018: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 58 | $24,984 | $63 |
| Psychotherapy with evaluation and management visit, 30 minutes | 35 | $3,847 | $55 |
| Return visit (30+ min) | 34 | $3,426 | $69 |
| Hospital discharge day management, more than 30 minutes | 33 | $3,353 | $96 |
| Short return visit (20+ min) | 25 | $2,504 | $43 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,659 | $119 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,544 | $91 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $1,052 | $34 |
2017: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 58 | $23,732 | $62 |
| Return visit (30+ min) | 36 | $2,967 | $62 |
| Hospital discharge day management, more than 30 minutes | 29 | $2,857 | $95 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,486 | $118 |
| New patient visit (45+ min) | 21 | $2,085 | $99 |
| Short return visit (20+ min) | 33 | $2,081 | $42 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 20 | $1,423 | $34 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,360 | $91 |
| Psychotherapy with evaluation and management visit, 30 minutes | 21 | $1,144 | $46 |
2016: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 54 | $31,898 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 62 | $19,507 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $6,830 | $155 |
| Return visit (30+ min) | 47 | $4,335 | $57 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 42 | $3,630 | $30 |
| Short return visit (20+ min) | 35 | $2,464 | $34 |
| Hospital discharge day management, more than 30 minutes | 19 | $1,798 | $86 |
| New patient visit (45+ min) | 11 | $1,243 | $113 |
2015: 14 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 106 | $24,797 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 79 | $24,656 | $84 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 84 | $7,609 | $31 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $7,234 | $161 |
| Return visit (30+ min) | 62 | $7,100 | $62 |
| Hospital discharge day management, more than 30 minutes | 31 | $2,786 | $87 |
| Short return visit (20+ min) | 39 | $2,589 | $37 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,196 | $100 |
| Return visit (30+ min) | 15 | $1,375 | $86 |
| Short return visit (20+ min) | 22 | $1,340 | $56 |
| Long return visit (40+ min) | 12 | $1,252 | $89 |
| Hospital discharge day management, 30 minutes or less | 13 | $765 | $59 |
| Short return visit | 19 | $760 | $27 |
| Psychotherapy with evaluation and management visit, 30 minutes | 12 | $524 | $40 |
2014: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 112 | $33,669 | $58 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 124 | $16,137 | $32 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 79 | $8,748 | $111 |
| Hospital discharge day management, 30 minutes or less | 75 | $4,467 | $59 |
| Short return visit | 56 | $3,784 | $32 |
| Psychotherapy with evaluation and management visit, 30 minutes | 37 | $3,609 | $52 |
| Short return visit (20+ min) | 35 | $2,919 | $57 |
2013: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 99 | $26,551 | $56 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 123 | $16,369 | $30 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 70 | $7,646 | $108 |
| Hospital discharge day management, 30 minutes or less | 80 | $4,824 | $57 |
| Short return visit | 45 | $2,838 | $27 |
| Short return visit (20+ min) | 32 | $1,896 | $41 |
| Psychotherapy with evaluation and management visit, 30 minutes | 33 | $1,783 | $27 |
| Psychotherapy with evaluation and management visit, 45 minutes | 16 | $618 | $39 |
Drugs they prescribed that Part D paid
$47,573
Pharmacies billed $47,573 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 453) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
438 generic and fewer than 11 brand-name prescriptions · $47,573 in drug cost · 74 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gabapentin | 39 | $984 | $25 |
| Sertraline | 31 | $897 | $29 |
| Mirtazapine | 54 | $890 | $16 |
| Quetiapine | 51 | $562 | $11 |
| Duloxetine | 17 | $520 | $31 |
See all 9 drugs
| Gabapentin | 39 | $984 | $25 |
| Sertraline | 31 | $897 | $29 |
| Mirtazapine | 54 | $890 | $16 |
| Quetiapine | 51 | $562 | $11 |
| Duloxetine | 17 | $520 | $31 |
| Bupropion Xl | 19 | $365 | $19 |
| Pregabalin | 17 | $264 | $16 |
| Trazodone | 17 | $238 | $14 |
| Clonazepam | 33 | $67 | $2 |
Year by year
| 2024 | 453 | 58 | 0% (0) | None | $47,573 |
| 2023 | 477 | 53 | None | None | $17,424 |
| 2022 | 381 | 44 | None | 5% | $21,862 |
| 2021 | 343 | 28 | None | 8% | $33,310 |
| 2020 | 472 | 54 | None | 8% | $53,965 |
| 2019 | 664 | 83 | None | None | $40,095 |
| 2018 | 649 | 96 | None | 14% | $52,312 |
| 2017 | 594 | 111 | 0% (0) | None | $50,461 |
| 2016 | 957 | 100 | None | 8% | $54,457 |
| 2015 | 1,287 | 125 | None | None | $93,831 |
| 2014 | 1,284 | 103 | None | None | $101,260 |
| 2013 | 1,008 | 101 | None | 15% | $82,688 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Mirtazapine | 56 | $1,536 | $27 |
| Gabapentin | 38 | $1,000 | $26 |
| Quetiapine | 48 | $915 | $19 |
| Liothyronine | 11 | $792 | $72 |
| Pregabalin | 18 | $481 | $27 |
| Duloxetine | 15 | $397 | $26 |
| Sertraline | 23 | $378 | $16 |
| Trazodone | 20 | $307 | $15 |
| Escitalopram | 13 | $280 | $22 |
| Olanzapine | 12 | $237 | $20 |
| Donepezil | 19 | $178 | $9 |
| Lamotrigine | 12 | $124 | $10 |
| Lithium Carbonate | 17 | $81 | $5 |
| Clonazepam | 27 | $72 | $3 |
2022: 16 drugs
| Fetzima | 12 | $5,815 | $485 |
| Mirtazapine | 35 | $1,351 | $39 |
| Liothyronine | 12 | $867 | $72 |
| Gabapentin | 42 | $607 | $14 |
| Sertraline | 16 | $560 | $35 |
| Quetiapine | 26 | $541 | $21 |
| Pregabalin | 13 | $484 | $37 |
| Ziprasidone | 11 | $476 | $43 |
| Duloxetine | 16 | $464 | $29 |
| Divalproex Sodium Er | 13 | $288 | $22 |
| Bupropion Xl | 15 | $266 | $18 |
| Trazodone | 12 | $236 | $20 |
| Lithium Carbonate Er | 12 | $225 | $19 |
| Escitalopram | 12 | $183 | $15 |
| Olanzapine | 11 | $155 | $14 |
| Clonazepam | 17 | $55 | $3 |
2021: 13 drugs
| Fetzima | 14 | $6,532 | $467 |
| Mirtazapine | 26 | $914 | $35 |
| Liothyronine | 12 | $867 | $72 |
| Quetiapine | 27 | $794 | $29 |
| Gabapentin | 45 | $604 | $13 |
| Sertraline | 11 | $553 | $50 |
| Bupropion Xl | 19 | $453 | $24 |
| Pregabalin | 12 | $334 | $28 |
| Duloxetine | 13 | $271 | $21 |
| Divalproex Sodium Er | 12 | $267 | $22 |
| Trazodone | 14 | $236 | $17 |
| Lithium Carbonate Er | 12 | $201 | $17 |
| Escitalopram | 13 | $163 | $13 |
2020: 18 drugs
| Vraylar | 14 | $24,828 | $1,773 |
| Fetzima | 12 | $5,236 | $436 |
| Quetiapine | 44 | $1,694 | $39 |
| Mirtazapine | 34 | $975 | $29 |
| Liothyronine | 13 | $884 | $68 |
| Gabapentin | 47 | $757 | $16 |
| Sertraline | 24 | $398 | $17 |
| Duloxetine | 15 | $386 | $26 |
| Bupropion Xl | 14 | $360 | $26 |
| Lithium Carbonate Er | 26 | $310 | $12 |
| Aripiprazole | 14 | $293 | $21 |
| Divalproex Sodium Er | 13 | $272 | $21 |
| Lamotrigine | 14 | $271 | $19 |
| Trazodone | 17 | $252 | $15 |
| Pregabalin | 18 | $243 | $13 |
| Escitalopram | 14 | $227 | $16 |
| Clonazepam | 13 | $95 | $7 |
| Olanzapine | 11 | $28 | $3 |
2019: 17 drugs
| Gabapentin | 82 | $1,303 | $16 |
| Bupropion Xl | 28 | $1,078 | $39 |
| Mirtazapine | 53 | $984 | $19 |
| Quetiapine | 44 | $967 | $22 |
| Duloxetine | 32 | $840 | $26 |
| Carbamazepine | 12 | $782 | $65 |
| Sertraline | 54 | $683 | $13 |
| Aripiprazole | 12 | $679 | $57 |
| Venlafaxine Hcl Er | 19 | $652 | $34 |
| Divalproex Sodium Er | 17 | $638 | $38 |
| Risperidone | 11 | $508 | $46 |
| Escitalopram | 30 | $453 | $15 |
| Trazodone | 23 | $303 | $13 |
| Olanzapine | 12 | $284 | $24 |
| Lithium Carbonate Er | 15 | $173 | $12 |
| Lamotrigine | 11 | $108 | $10 |
| Amlodipine Besylate | 11 | $71 | $6 |
2018: 16 drugs
| Lyrica | 20 | $11,664 | $583 |
| Aripiprazole | 20 | $4,215 | $211 |
| Trintellix | 12 | $2,647 | $221 |
| Mirtazapine | 59 | $1,724 | $29 |
| Duloxetine | 25 | $1,155 | $46 |
| Bupropion Xl | 26 | $798 | $31 |
| Divalproex Sodium Er | 17 | $573 | $34 |
| Escitalopram | 51 | $552 | $11 |
| Gabapentin | 51 | $444 | $9 |
| Trazodone | 21 | $305 | $15 |
| Quetiapine | 19 | $265 | $14 |
| Olanzapine | 13 | $232 | $18 |
| Sertraline | 25 | $145 | $6 |
| Lithium Carbonate | 17 | $117 | $7 |
| Lorazepam | 14 | $116 | $8 |
| Venlafaxine Hcl Er | 14 | $98 | $7 |
2017: 15 drugs
| Lyrica | 17 | $6,880 | $405 |
| Trintellix | 11 | $3,346 | $304 |
| Duloxetine | 38 | $2,236 | $59 |
| Mirtazapine | 66 | $2,159 | $33 |
| Bupropion Xl | 28 | $811 | $29 |
| Olanzapine | 13 | $769 | $59 |
| Divalproex | 17 | $613 | $36 |
| Gabapentin | 47 | $510 | $11 |
| Escitalopram | 50 | $464 | $9 |
| Quetiapine | 31 | $345 | $11 |
| Venlafaxine Hcl Er | 12 | $234 | $20 |
| Trazodone | 18 | $217 | $12 |
| Risperidone | 13 | $158 | $12 |
| Sertraline | 18 | $108 | $6 |
| Lithium Carbonate | 11 | $74 | $7 |
2016: 20 drugs
| Mirtazapine | 69 | $3,632 | $53 |
| Duloxetine | 34 | $2,653 | $78 |
| Risperidone | 67 | $2,453 | $37 |
| Divalproex | 32 | $2,345 | $73 |
| Divalproex Sodium Er | 14 | $2,101 | $150 |
| Gabapentin | 172 | $1,754 | $10 |
| Quetiapine | 69 | $1,176 | $17 |
| Bupropion Xl | 33 | $1,043 | $32 |
| Venlafaxine Hcl Er | 36 | $849 | $24 |
| Escitalopram | 49 | $409 | $8 |
| Trazodone | 40 | $394 | $10 |
| Polyethylene Glycol 3350 | 22 | $393 | $18 |
| Clonazepam | 31 | $370 | $12 |
| Valsartan | 11 | $233 | $21 |
| Sertraline | 14 | $229 | $16 |
| Donepezil | 19 | $158 | $8 |
| Warfarin | 13 | $151 | $12 |
| Levothyroxine | 13 | $147 | $11 |
| Lorazepam | 18 | $85 | $5 |
| Citalopram Hbr | 12 | $69 | $6 |
2015: 27 drugs
| Abilify | 18 | $18,311 | $1,017 |
| Risperidone Odt | 30 | $5,272 | $176 |
| Duloxetine | 35 | $5,150 | $147 |
| Divalproex Sodium Er | 20 | $4,874 | $244 |
| Lyrica | 14 | $4,560 | $326 |
| Divalproex | 19 | $2,451 | $129 |
| Gabapentin | 187 | $2,338 | $13 |
| Mirtazapine | 109 | $2,237 | $21 |
| Risperidone | 72 | $2,043 | $28 |
| Olanzapine Odt | 19 | $1,943 | $102 |
| Polyethylene Glycol 3350 | 38 | $1,192 | $31 |
| Quetiapine | 83 | $1,132 | $14 |
| Olanzapine | 22 | $999 | $45 |
| Bupropion Xl | 16 | $645 | $40 |
| Lansoprazole | 17 | $637 | $37 |
| Escitalopram | 63 | $591 | $9 |
| Levothyroxine | 43 | $563 | $13 |
| Tamsulosin | 11 | $522 | $47 |
| Venlafaxine Hcl Er | 25 | $379 | $15 |
| Fludrocortisone Acetate | 12 | $314 | $26 |
| Trazodone | 43 | $282 | $7 |
| Citalopram Hbr | 35 | $238 | $7 |
| Clonazepam | 39 | $236 | $6 |
| Warfarin | 21 | $207 | $10 |
| Lorazepam | 27 | $167 | $6 |
| Donepezil | 18 | $162 | $9 |
| Sertraline | 14 | $82 | $6 |
2014: 29 drugs
| Abilify | 22 | $14,961 | $680 |
| Duloxetine | 42 | $8,646 | $206 |
| Risperidone | 63 | $3,426 | $54 |
| Lidocaine | 12 | $3,207 | $267 |
| Lyrica | 11 | $3,037 | $276 |
| Gabapentin | 193 | $2,709 | $14 |
| Mirtazapine | 107 | $2,239 | $21 |
| Quetiapine | 97 | $2,124 | $22 |
| Polyethylene Glycol 3350 | 40 | $1,636 | $41 |
| Olanzapine Odt | 26 | $1,519 | $58 |
| Olanzapine | 18 | $1,149 | $64 |
| Galantamine Hbr | 13 | $882 | $68 |
| Venlafaxine Hcl Er | 19 | $758 | $40 |
| Divalproex | 12 | $692 | $58 |
| Oxcarbazepine | 11 | $672 | $61 |
| Escitalopram | 33 | $634 | $19 |
| Bupropion Hcl Sr | 20 | $614 | $31 |
| Bupropion Xl | 13 | $569 | $44 |
| Levothyroxine | 41 | $535 | $13 |
| Methylphenidate | 11 | $451 | $41 |
| Fludrocortisone Acetate | 14 | $359 | $26 |
| Citalopram Hbr | 47 | $356 | $8 |
| Lorazepam | 35 | $336 | $10 |
| Clonazepam | 42 | $305 | $7 |
| Metoprolol | 19 | $187 | $10 |
| Alprazolam | 14 | $126 | $9 |
| Lisinopril | 17 | $105 | $6 |
| Trazodone | 14 | $92 | $7 |
| Atenolol | 16 | $66 | $4 |
2013: 24 drugs
| Cymbalta | 36 | $15,258 | $424 |
| Abilify | 16 | $12,287 | $768 |
| Quetiapine | 91 | $4,738 | $52 |
| Risperidone | 71 | $4,459 | $63 |
| Olanzapine Odt | 19 | $4,260 | $224 |
| Escitalopram | 48 | $2,947 | $61 |
| Risperidone Odt | 11 | $1,448 | $132 |
| Gabapentin | 106 | $1,189 | $11 |
| Venlafaxine Hcl Er | 28 | $1,097 | $39 |
| Divalproex | 26 | $1,086 | $42 |
| Mirtazapine | 65 | $972 | $15 |
| Polyethylene Glycol 3350 | 32 | $966 | $30 |
| Citalopram Hbr | 36 | $369 | $10 |
| Levetiracetam | 12 | $342 | $28 |
| Lamotrigine | 11 | $304 | $28 |
| Zolpidem | 22 | $244 | $11 |
| Lorazepam | 40 | $216 | $5 |
| Fludrocortisone Acetate | 12 | $195 | $16 |
| Omeprazole | 13 | $176 | $14 |
| Sertraline | 13 | $124 | $10 |
| Levothyroxine | 13 | $123 | $9 |
| Trazodone | 19 | $114 | $6 |
| Losartan | 12 | $111 | $9 |
| Atenolol | 11 | $68 | $6 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1144394586
- Licence
- CA A87628California A87628: Current · expires 2027-11-30
- Trained
- Loma Linda University School of Medicine, 2000
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2084P0805X (2084P0805X); Psychiatry (2084P0800X)
- Mailing address
- 300 Pasteur Dr, Palo Alto, CA, 94304
- NPI first listed
- 2006-11-18
- NPI last updated
- 2024-04-30
- NPI record certified
- 2024-04-30
This is when the NPI record was last certified, not a medical board exam.